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CHAPTER I 
INTRODUCTION 
Anaplasma marginale Thei.ler is a rickettsial infection of bovine 
erythrocytes. The disease is transmitted mechanically by the bites of 
horseflies (Tabanidae} and possibly other biting flies. Ticks are the 
only known biological vector of this disease and are probably responsible 
for its continuation (Oikmans 1950, Howell 1957). Factors that account 
for the efficiency of ticks as vectors of Anaplasmosis are (1) they 
attach firmly and do not dislodge easily; (2) they are slow feeding 
which permits efficient transfer of the pathogen; (3) their longevity 
i.ncreases. the chance of acquiring and transmitting the disease; (4) they 
are relatively free from natural enemies; and (5) they are resistant to 
envi.ronmenta 1 stresses (Harwood and James 1979). 
Of the ticks implicated as vectors of anaplasmosis Dermacentor 
variabilis (Say) and Q_. andersoni Stiles are the most important. Several 
authors have demonstrated the vector ability of experimentally and natur-
ally infected ticks of these species and transtadial transmission of the 
pathogen (Anthony and Roby 1962, Kocan et al. 1980, Kocan et al. 1981, 
Boynton et al. 1936). Howell et al. (1941) demonstrated transovarial 
transmission by Q_. andersoni but subsequent research has failed to sub-
stantiate this. Transmi.s.sion of the pathogen to the bovine host may be 
liy the bi.te or by contamination of the tick feces. 
A. marginale causes an acute, subacute, or chronic infectious 
anemia of th.e bovi.ne. Tbe dis.eas.e is us.ually mild in calves up to l 
year old and acute in older cattle (Ri.s.tic 1960}. Survival of infected 
animals is. increased if the disease is diagnosed and treated early be-
fore onset of complications resulting from the anemia. A vaccine is 
available for anaplasmosis but treatment with tetracyclines remains 
important i.n the control of the disease. 
Tetracyclines Used in the Treatment 
and Control of Anaplasmosis 
2 
The only chemotherapeutic compounds available for use against ana-
pl asmos.is. in the United States are oxytetraycline, chlortetracycline, 
and tetracycline hydrochloride. They are approved for intramuscular 
(IM) and intravenous (IV) injection and oral administration. They show 
similar activity in inhibiting reproduction by fl. marginale (Simpson 
1975, Brock 1959). 
Treatment of anaplasmosis is most commonly affected by IM or IV 
administration of one of the tetracyclines. Foote et al. (1951) were 
the first to note the effectiveness of IV administered chlortetracycline 
against anaplasmosis. f•liller et al. (1953) reported slightly better 
s.uccess i.n treating anaplasmosis with chlortetracycl ine IV than with 
oxytetracycli.ne IV especially when the disease was treated early in its 
course. Foote and Wulf (1952) reported that doses of 27.5 to 47.5 grams 
of chlortetracycline administered over 3 days eliminated the infection 
from bovine erythrocytes. This was refuted by Pearson and Brock (1953) 
who reported that dos.ages of 47 .5 g only temporarily suppressed the 
infection and did not eliminate it. Several authors have reported 
s:ucces.s. in el i.mi.nati.ng the carrier state by treating the animal with 
high levels of tetracyclines for 5 to 10 days or the use of a long 
acting oxytetracycline (Pears:on et al. 1957, Magonigle et al. 1975, 
Robey et al. 1978}. Other authors: demonstrated that acute cases of 
anaplasmosis can be successfully treated with 3 treatments of oxytet-
racycli.ne formulated at 50 mg/ml or l treatment of a long-acting oxy-
tetracycline formulated at 200 mg/ml (Kuttler 1971, Kuttler and Simpson 
1978, Wilson et al. 1979}. 
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Feeding cblortetracycli.ne is an accepted method for the prevention 
of anaplasmosis and the elimi.nation of the carrier state. Several auth-
ors have reported successfully preventing anaplasmosis or eliminating 
the carrier state by feeding chlortetracycline to animals on drylot at 
a dosage of l .1 mg/kg body weight for periods of 60 to 120 days (Brock 
et al. 1957, Franklin et al. 1967, Richey et al. 1977). Similar studies 
were conducted on pastured animals and reductions in the number of car-
ri.er animals were reported but the reduction was accomplished over long-
er periods of time than in animals kept on drylot. This reduction in 
effictency may be due to the poor palatibility of the medicated feeds 
or to the variable consumption of the medicated feeds. 
Discussion of Research Problem 
Anaplasmosis is spreading in the United States. ~kCallom (1976) 
estimated that at that time 50,000 to 100,000 animals died of the dis-
ease. Losses were estimated to exceed 100 million dollars a year from 
these deaths and abortions caused by lack of oxygen to the fetus. A 
vaccine is: available but it does.. not eliminate the carrier state of 
the di.s..eas.e. Treatment ustng the tetracyclines remains an important 
method of l fmiting the losses. caused by anaplasmosis. Early diagnosis 
is. di. ffi.cul t becaus.e tb.e di.s.eas.e can remain undetected by the producer 
until the ani:ma l i.s. to sick to b.e treated wi.thout ri.s.k (Koger 1962, 
Kuttler 1973}. 
Recent res:earch at Oklahoma State University has been aimed at 
making treatment and prophylaxis of the disease more cost effective 
and les.s. detrimental to the animal by using sustained-release boluses 
(Byford 1980, 1981). To accomplish this it was important to determine 
i.f oxytetracycline or chl ortetracycl ine is more efficient for control 
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of the disease; and to determine if a tetracycline could prevent infect-
ed ticks from transmitting A. marginale to uninfected cattle. 
CHAPTER II 
THE BIOEQUIVALENCY OF OXYTETRACYCLINE AND 
CHLORTETRACYCLINE FOR CONTROL OF TICK 
TRANSMITIED ANAPLASMOSIS 
Previous researchers have reported that low level treatment with 
tetracyclines administered orally or by injection for extended periods 
of time can control bovine anaplasmosis (Pearson et al. 1957, Byford et 
al. 1981). Recent research at Oklahoma State University has indicated 
that s.uch dosages could be administered via a sustained-release bolus 
(Byford et al. 1981). To further the efficiency of this administration 
system and others using orally administered tetracyclines, it was deter-
mined that a bioequivalency study was necessary. The purpose of this 
study was to determi.ne if oxytetracycline or chlortetracycline is more 
efficient for the control of tick transmitted anaplasmosis. 
Materials and r1ethods 
Test animals consisted of seven Holstein and Jersey dairy cows 
that were 4-6 years of age. Wright-stained blood smears and the ana-
plasmosis complement-fixation test were used to determine if the test 
animals had any previous exposure to anaplasmosis. 
The cattle were randomly divi.ded into 2 test groups of 3 animals 
each and 1 animal served as a control. All test animals were maintained 
under drylot conditions on a cottonseed hull based ration and wheat 
5 
6 
straw free-choi.ce to mi.ni.rrrize wei.ght gain. Group 1 recei.ved oxytetra-
cycl foe at a dos.age rate of 1 .1 mg/kg body weight. Group II received 
chlortetracycline at a dosage rate of 1 .1 mg/kg body weight. Both drugs 
were administered orally using gelatin capsules containing the drug and 
barium sulfate to increase the density of the capsule. Drug dosages 
for each animal were determined from weekly weight measurements. Admin-
istration of the drugs began on test day 0 and continued for 120 days. 
Anaplasmosis infective Q_. variabilis were obtained by feeding the 
nymphal ticks on a cow inoculated with fl. marginale that developed a 
peak parasitemia of 35.6 percent. All ticks for this study were fed on 
one infected cow to minimize differences in infectivity of ticks. These 
ticks were allowed to molt to the adult stage for use in this study. 
On day 10 of the study all test animals were placed in stanchions 
and exposed to fl. marginale by feeding the infective adult ticks on the 
susceptible animals. The animals were subsequently monitored 3 times 
each week until the appearance of marginal bodies and daily thereafter 
to determine the bioequivalency of the drugs. Packed cell volumes, the 
anaplasmosis complement fixation tests, and parasitemia values were mea-
sured at each samp 1 i ng to determine the efficacy of each drug therapy. 
Monitoring of the animals continued for 120 days. 
Results and Discussion 
Transmission of anaplasmosis by infected ticks was achieved in 
those animals receiving oxytetracycline and in the control animal. The 
influence of each treatment is. shown i.n Table I. The control animal 
developed a severe case of anaplasmosis as is evident from the minimum 
PCV of 10..5 percent and the loss of 86.4 kgs. from the mean preinfection 
Treatment 
Oxytetracycline 
Uxytetracyc line 
Oxytetracycline 
Chlortetracycline 
Chlortetracycline 
Chlortetracycline 
Control 
TABLE I 
BIOEQUIVALENCY OF OXYTETRACYCLINE AND CHLORTETRACYCLINE 
FOR THE CONTROL OF TICKa TRANSMITTED ANAPLASMOSIS 
Cow Prepatentb Packed Cell Volumec 
Number Period Mean Minimum 
{days) Preinfection Percent 
509 27 34.0 20.5 
528 43 33.5 23. 0 
3067 28 31.5 25.5 
322 
3068 
3178 
448 27 33.0 10. 5 
a All ticks infected on cow number 203. 
Peak 
Parasitemia 
Percent 
l.6d 
0.8d 
0.6d 
0.0 
0.0 
13. 2d 
b Prepatent period determined from day 5 post attachment to appearance of marginal bodies 
in stained blood smears. 
c Packed cell volumes reported for animals showing an infection of fl. marginale. 
d Positive reaction to CF titer at 1:5 dilution of serum " 
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weight even though tb.e peak paras:itemia was 13.2 percent. Tb.e animals. 
receiving 1.1 mg/k.g b.ody weight of oxytetracycli.ne developed mi.ld cas.es 
of anaplasmosis. as evidenced by the peak parasitemi a of the anima 1 s (1. 6, 
0.8 and 0.6 percentl. The animals. receiving 1.1 mg/kg body weight of 
cb.lortetracycli.ne showed no signs of anaplasmosis in the stained blood 
smears. or in the complement fi.xation test. 
Treatment with oxytetracycline showed some effectiveness in limit-
ing the infection in those animals receiving it. It was also effective 
i.n preventing expression of clinical signs of the disease. Treatment 
with cblortetracycline was completely effective in preventing infection 
i.n those animals receivi.ng it. Based on the results of these treatments 
chlortetracycline proved to be more efficient for the control of anapla-
mos.i s. than oxytetracyc line. 
CHAPTER III 
INHIBITION OF TICK TRANSMISSION OF ANAPLASMOSIS 
BY ORALLY ADMINISTERED CHLORTETRACYCLINE -
TRAIL I 
Tetracyclines are the only chemotherapeutic compounds available 
for use against anaplasmosis in the United States. No research has been 
conducted concerning the ability of these compounds to inhibit the trans-
mission of anaplasmosis by ticks. Because of their common use in the 
control and treatment of the disease this aspect of the .transmission 
cycle was considered important. If the tetracyclines could inhibit the 
transmission of the disease, the disease cycle could be broekn at two 
points; the bovine host and the tick vector of the disease. The purpose 
of this study was to determine if infected adult ticks could be prevented 
from transmitting anaplasmosis to uninfected cattle. 
Materials and Methods 
Test animals for the first part of this study consisted of 4 Hol-
stein dairy cows that were 4-6 years of age. Wright-stained blood smears 
and the complement-fixation test were conducted to determine if these 
animals had any previous exposure to anaplasmosis. 
Al 1 ticks. used in this. study were infected as. nymphs with fl. mar-
ginale b.y placing them on a calf inoculated with this disease. To 
minimize possible differences in infectivity, nymphal D. variabil is 
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were fed on one calf. They were s.ub.s.equently allowed to molt to the 
adult s.tage for us.e fn tb.i.s. s.tudy. 
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The 4-6 year old dai.ry cows. were as.s.igned a treatment regiment as 
shown in Table II. One cow was not treated with chlortetracycline and 
s.erved as. a control. Tbe remaini.ng 3 cows received chlortetracycl ine 
at dosage rates of 1 .0, 2.0 and 3.0 mg/kg body weight. The treatments 
were admi.ni.stered orally using gelatin capsules containing the drug and 
bari.um s.ufl ate to increase the density of the capsule to prevent regur-
gi.tati.on. Drug dos.ages for each animal were determined from weekly 
weight measurements. Administration of the drug began on test day O 
and continued for 120 days. On day 10 of the study the cows were placed 
i.n stanchions and exposed to 100 pair of infected female Q. variabilis. 
They were s.ubsequently monitored 3 times each week until the appearance 
of marginal bodies in a stained blood smear and daily thereafter. Pack-
ed cell volumes. and the anaplasmosis complement-fixation test were used 
in addition to the stained blood smear to monitor the progress of the 
dis.ease. 
Splenectomi.zed calves were used to indicate the effect of the drug 
treatment given to the dairy cows on the infectivity of the ticks. Gut 
homogenate was prepared from a pool of 50 of the infected ticks removed 
from a cow on day 16 of the test. The gut homogenate from the appropri-
ate cow was injected into a splenectomized calf according to Table II. 
The calves were monitored 3 times each week until marginal bodies appear-
ed i.n the stained blood smear and daily thereafter. Packed cell volumes 
and the anaplasmosi.s complement-fi.xation test were used to aid in mon-
Hori.ng the progress of the disease. 
TABLE II 
DESIGN OF DRUG THERAPY AND INJECTION OF GUT 
HOMOGENATE TO DETERMINE INHIBITION OF 
TICK TRANSMISSION OF ANAPLASMOSIS 
11 
Chlortetracycline Cow a Gut Homogenateb 
Dosage Number from Cow Injected 
into Calf Number 
Contra l 3068 Jl 
1.0 mg/kg 3125 J2 
2.0 mg/kg 3178 J3 
3.0 mg/kg 3131 J4 
a All cows were infested with 100 adult D. variabilis on day 10 of study. 
b Gut homogenate from a pool of 50 ticks. 
Results. and Discussion 
The 4-7 year old dairy cows did not develope an fl. marginale 
infection as was: shown by negative CF titers and the absence of mar-
ginal bodies in the stained blood smears for the monitoring period 
of 120 days. The ticks were found to be infective when gut homogen-
ates. prepared from them caused an infection in the splenectomized 
ca 1 ves. used in this study. Therefore why the dairy cows remained un-
infected could not be explained. 
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All calves injected with the gut homogenate did develope A. mar-
ginale infections. Results of this part of the study are presented in 
Table III. The prepatent period for all calves was in the normal range 
and showed no significant pattern in relation to the level of chlortet-
racycline administered. Peak parasitemia also showed no pattern in 
relation to the level of chlortetracycline administered. The data indi-
cate that chlortetracycline administered at these rates had no effect on 
the abili.ty of ticks. to transmit fl. marginale between bovine hosts. This 
may be due to the dosage level administered to the cow was insufficient 
to maintain the blood concentration at a level that would reduce the 
infectfvity of the tick. It is also possible that sufficient levels 
were not maintained within the tick for a long enough period to reduce 
the infectivi.ty of the tick due to the limited time in which feeding 
actually occurred. Feeding trials involving the bovine host have demon-
strated success. in eliminating the carrier state with low levels of tet-
racyclines but only if the drug was administered for 60 to 120 days. 
Recent s.tudies. by Kocan et al. (1980} demonstrated that the development 
sites of A. marginale in the tick vector is within the gut epithelial 
Chlortetracycline 
Dosage 
Administered Cow 
Control 
l. 0 mg/kg 
2.0 mg/kg 
3.0 mg/kg 
TABLE III 
INFLUENCE OF CHLORTETRACYCLINE ON THE TRANSMISSION 
OF ANAPLASMOSIS BY TICKS 
Calf Prepatenta Packed Cell Volume 
Number Period Mean Minimum 
(days) Preinfection Percent 
Jl 29 33.5 10.0 
J2 26 33.0 12.5 
J3 28 31 .0 17.0 
J4 31 39.5 ll. 5 
Peak 
Paras itemi a 
Percent 
15.6b 
33.Bb 
13. lb 
26.9b 
a Prepatent period determined from day of injection of gut homogenate to appearance of 
marginal bodies in the stained blood smears. 
b Positive reaction to CF titers at 1:5 dilution of serum. 
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ce11s.. It is. possible that ch.lortetracycli.ne did not penetrate the 
gut epi.thel ium tn s.uffi.c"ient concentrati.on to reduce the i.nfecti.vity 
of the tick. 
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Th.e results of th.i.s. study indicated that cblortetracycline admin-
istered orally to the bovine host had no effect on the abi 1 i ty of ticks 
to transmit A. margi.na 1 e. The reason for this was not known and further 
s.tudi.es were conducted to study this prob 1 em further. 
CHAPTER IV 
INHIBITION OF TICK TRANSMISSION OF ANAPLASMOSIS 
BY ORALLY ADMINISTERED CHLORTETRACYCLINE-
TRIAL II 
After the completion of Trial I, it was determined that the use of 
gut homogenates prepared from ticks parasitizing chlortetracycline treat-
ed cattle, was. insufficient to test the effect of the treatment on the 
tick 1 s infectivi.ty. Also the anomalous results obtained from the dairy 
cows contributed to the need for a second study to eliminate the pos-
sibility of contamination of the gut homogenate and to simulate a field 
situation. Transfer of live whole ticks to susceptible splenectomized 
dai.ry calves were used as a further indicator of the effect of the 
treatment regiment. 
Test animals for this study were 2 Ayrshire dairy cows, 4-7 years 
of age and 6 splenectomized Holstein dairy calves. The cattle were 
treated as shown in Table IV. One dairy cow served as an untreated 
control and chlortetracycline was administered to the other dairy cow 
at a dosage rate of 3 mg/kg body weight in 2 daily doses until day 72 
in the same manner as before. After exposure to 100 pair of infected 
D. andersoni on day 10 hematologic and serologic tests previously 
described were used to monitor the progress of the disease. The splen-
ectomized calves. were treated as. shown in Table IV. After administra-
ti:on of the appropriate treatment to the splenectomized calves 
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TABLE IV 
DESIGN OF DRUG THERAPY, INJECTION OF GUT HEMOGENATE, 
AND TRANSFER OF TICKS TO DETERMINE INHIBITION 
OF TICK TRANSMISSION OF ANAPLASMOSIS 
16 
Chlortetracycline Cow Cut Homogenate Tick transferred 
Dosage Number from Cow Injected from Cow onto 
into Calf Number Calf Number 
Contra 1 710 384 388 
406 
3 mg/kg 3042 404 386 
405 
hematologic and s.erologi.c tes.ts. were conducted as. previ.ous.ly des.cri.bed 
to moni.tor tb.e progres:s. of the dis.ease i.n the calves. 
Results and Discussion 
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The 4-7 year old dairy cows developed an fl. marginale infection as 
shown in Table V. The prepatent period was in the normal range for 
cattle infected by tick vectors. It should be noted that the prepatent 
period of the cow treated with chlortetracycline is not definite because 
the complement fixation test for anaplasmosis remained negative. The 
peak parasi.temia of the cow treated with chlortetracycline did not reach 
a level sufficient to cause clinical symptoms or a significant decrease 
in the packed cell volume. The minimum packed cell volume noted in 
Table V did not follow the peak parasitemia as is common in anaplasmosis 
and therefore was not due to the disease. The data indicate that 3 mg/ 
kg body weight of chlortetracycl ine is suffi.cient to prevent expression 
of cHni.cal symptoms of anaplasmosis. 
All calves injected with gut hemogenate or parasitized by the 25 
pair of ticks developed an fl. marginale infection. These results are 
presented in Table V. As was noted in the initial study the prepatent 
period was within the normal 20-25 day prepatent period expected and 
s.howed no pattern in relation to the treatment received by the dairy 
cow the ticks were initially fed on. Peak parasitemia also showed no 
significant pattern in relation to the treatment received by the dairy 
cow. The data indicate that chlortetracycline did not have an affect 
on the abi.li.ty of ti.cks. to transmit fl. marginale between bovine hosts 
as in the initial study. This study further indicated that injection 
of gut hemogenates accurately reflected the ability of the tick to 
CALVES 
Number 
384 
386 
388 
404 
405 
406 
cows 
710 
3042 
TABLE V 
INFLUENCE OF CHLORTETRACYCLINE ON THE TRANSMISSION 
OF ANAPLASMOSIS BY TICKSa 
(%) 
Cow Pre patent Peak Para- Init X 
Ticks from Period sitemi a PCV 
710 17a,b 51.2 33.5 
3042 24 c 48.2 33.6 
710 25 c 34.0 32.2 
3042 22 b 34.2 30.4 
b 
3042 21 41.6 34.2 
710 20 b 41.2 39.2 
23 c 23.2 31.5 
30 d 0.2 41.5 
a All ticks infected on calf number 378. 
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Low 
PCV 
10.0 
* 10.0 
* 8.5 
10.0 
10.0 
8.5 
* 9.5 
35.0 
b Prepatent period determined from day of injection of gut hemogenate 
to appearance of marginal bodies in the stained blood smears. 
c Prepatent period determined from day 5 post attachment to appearance 
to marginal bodies in stained blood smears. 
d Prepatent period determined from day 6 post attachment to suspected 
appearance of marginal bodies in stained blood smears. 
transmit 8_. marginale after feeding on antibiotic treated cattle. This 
finding agrees with res.earch conducted by Kocan et a1. (1980} which 
demonstrated that the development site of A. marginale in the tick is 
is within the gut epithelia. 
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Trial I and this study indicated that orally administered chlor-
tetracycline cannot destroy or reduce the infectivity of ticks para-
s.i.tizing a treated cow. Increasing the dosage rate administered to the 
host animal might prove to be effective in reducing the infectivity of 
ticks but would probably be prohibitively expensive. Also increased 
dos.age rates. would not be practical with present sustained release systems. 
Adding suffi.ci.ent quantities. to feed would probably not be feasible be-
cause of the reduction in the feeds palatibility which would reduce the 
actual dose received by the animal. In summary chlortetracycline does 
not show an ability to reduce the efficiency of tick transmission of 
anaplasmosis. 
CHAPTER V 
SUMMARY AND CONCLUSIONS 
The objective of these studi.es was to evaluate the efficacy of 
oxytetracycline and chlortetracycline for the prevention of anaplasmosis 
and to determine if chlortetracycline would inhibit the transmission of 
anaplasmosis. by ticks. These factors were determined to be important 
to aid in the development of the most practical and efficient sustained-
releas.e bolus to be used for control and prevention of anaplasmosis. 
Data from the bioequivalency study indicated that chlortetracycline 
was more efficient than oxytetracycline for the control of tick born 
anaplasmosis, when the drugs were administered orally. The oxytet-
racycl ine treated animals developed mild infections, therefore demon-
strati.ng oxytetracycline 1 s benefits whereas the chlortetracycline treated 
animals remained free of infection. 
Data from the study on chlortetracycline 1 s ability to inhibit ana-
plasmosis transmission, indicated that ticks remain infective after 
feeding on chlortetracycline treated animals. This was demonstrated 
by the successful transmission of the disease to susceptible calves by 
gut homogenates and transfer of ticks that were parasitizing treated 
cattle. This study indicated that the transmission cycle of~- marginale 
could not be effectively interrupted in the tick by the use of chlortet-
racycl tne. 
The tetracycl i.nes have been important in the control of anaplasmosis 
20 
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but current methods. of treatment are 1 ab.orious.. When tetracycl ~nes. 
are added to feeds. their effecti:ve.ness: agai:ns:t anaplas.mos:i.s. is: variable 
due to the reduced palatibility of the feed. The oxytetracycline sus-
tained-release bolus: reported on by Byford et al. (1981} was shown to 
be effecti.ve agai.ns:t anaplasmos.i.s. and could solve these problems. The 
results of tbe.se studies indicate that the efficiency of this system 
could be increased by using chlortetracycline as the active ingredient 
tns:tead of oxytetracycline. 
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